(Q47860884)

6 February 2018

title

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers (English)

1 reference

6 February 2018

0 references

1 reference

14

Hoffman SL

1 reference

6 February 2018

Le TP

1

1 reference

6 February 2018

Coonan KM

2

1 reference

6 February 2018

Hedstrom RC

3

1 reference

6 February 2018

Charoenvit Y

4

1 reference

6 February 2018

Sedegah M

5

1 reference

6 February 2018

Epstein JE

6

1 reference

6 February 2018

Kumar S

7

1 reference

6 February 2018

Wang R

8

1 reference

6 February 2018

Doolan DL

9

1 reference

6 February 2018

Maguire JD

10

1 reference

6 February 2018

Parker SE

11

1 reference

6 February 2018

Hobart P

12

1 reference

6 February 2018

Norman J

13

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

18

1 reference

6 February 2018

issue

18

1 reference

6 February 2018

page(s)

1893-1901

1 reference

6 February 2018

Direct gene transfer into mouse muscle in vivo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

1 reference

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Living up to the legacy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Potential DNA vaccine integration into host cell genome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Do DNA vaccines induce autoimmune disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Multi-gene vaccination against malaria: A multistage, multi-immune response approach

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Toward clinical trials of DNA vaccines against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

An OspA-Based DNA Vaccine Protects Mice against Infection with Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Safety Evaluation in Rodents and Non-Human Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Safety considerations for nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Range of antinuclear antibodies in "healthy" individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900407-7

7 January 2021

10.1016/S0264-410X(99)00407-7

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018